Cullinan Therapeutics
Social media
Cullinan Therapeutics Logo
About Cullinan Therapeutics
Cullinan Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing a diversified pipeline of targeted therapies for cancer and autoimmune diseases. Its portfolio includes small molecules, antibodies, and fusion proteins in clinical trials for indications such as non-small cell lung cancer, solid tumors, multiple myeloma, acute myeloid leukemia, and autoimmune disorders. The company leverages a modality-agnostic approach to identify and pursue the most effective therapeutic strategies, collaborating with industry partners to advance its programs. Headquartered in Cambridge, Massachusetts, Cullinan Therapeutics serves patients globally.
Address
One Main Street, Suite 1350
Cambridge, 02142
United States
Year founded
2016
Number of employees
100-200
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
